Mostrando 10 resultados de: 32
Filtros aplicados
Publisher
American Journal of Therapeutics(11)
Revista Latinoamericana de Hipertension(8)
Current Pharmaceutical Design(3)
Journal of Diabetes Research(2)
Journal of Obesity(2)
Área temáticas
Enfermedades(24)
Fisiología humana(19)
Farmacología y terapéutica(9)
Salud y seguridad personal(7)
Medicina y salud(6)
Área de conocimiento
Medicina interna(9)
Obesidad(7)
Diabetes(6)
Enfermedad cardiovascular(4)
Epidemiología(4)
AMPK as target for intervention in childhood and adolescent obesity
ReviewAbstract: Childhood obesity is a major worldwide health problem. Intervention programs to ameliorate the ratePalabras claves:Autores:Aguirre M.A., Arráiz N., Rojas-Quintero J., Valmore Bermúdez, Velasco M.Fuentes:scopusAssociation between apoliprotein E gene polymorphism and hypercholesterolemic phenotype in maracaibo, Zulia State, Venezuela
ArticleAbstract: Apoliprotein (Apo) E gene polymorphisms have been associated with high plasma lipids levels and cardPalabras claves:ApoE, Cardiovascular disease, hypercholesterolemia, Lipids profile, polymorphismsAutores:Arráiz N., Carem Prieto, Escalona C., Reyes F., Rondón N., Sánchez M.P., Sanz E., Valmore Bermúdez, Velasco M.Fuentes:scopusBiochemical and clinical characterization of metabolic phenotypes: A cross-sectional study from Maracaibo city, Venezuela
ArticleAbstract: Background: In 1980, Reuben Andresen observed that in certain individuals, obesity did not increasePalabras claves:Coronary risk, Metabolic phenotypes, Metabolically healthyobese, Metabolically unhealthy lean, Two-step clusterAutores:Añez-Ramos R., Calvo M.J., Cerda M., Garicano C.M.D., Graterol M., Graterol R., Hernández J.D., Martínez M.S., Mindiola A., Olivar L.C., Rojas-Quintero J., Salazar-Vílchez J., Valmore Bermúdez, Velasco M., Wilches-Duran S.Fuentes:scopusBiologic Behavior and optimal cut-off point estimation for Serum Fasting Insulin: A report from the Maracaibo City Metabolic Syndrome Prevalence Study
ArticleAbstract: Introduction: Insulin resistance is a metabolic state in which tissue effects of insulin are diminisPalabras claves:Cut-off point, hyperinsulinemia, Insulin, Insulin Resistance, Metabolic syndromeAutores:Amell A., Arráiz N., Calvo M.J., Carem Prieto, Chávez C., Chávez-Castillo M., David A., Escalona C., Gómez M.C., Lubo A., Martínez M.S., Mengual-Moreno E., Rojas-Quintero J., Romero J., Salazar-Vílchez J., Toledo A., Valero P., Valmore Bermúdez, Velasco M.Fuentes:googlescopusEffect of drugs interacting with the dopaminergic receptors on glucose levels and insulin release in healthy and type 2 diabetic subjects
ArticleAbstract: Dopamine agonists play an important role in the regulation of the central nervous-cardiovascular, rePalabras claves:dopamine, Dopaminergic agonists, Dopaminergic receptors, Hypertension, Insulin, Type 2 Diabetes mellitusAutores:Bolívar H., Cano R.A., Contreras F., Foullioux C., Lares M., Leal E.M., Maroun C., Pacheco B., Valmore Bermúdez, Velasco M.Fuentes:scopusDetermination of Non-HDL cholesterol in diabetic and hypertensive patients
ArticleAbstract: Recently, it has been suggested that non-high-density lipoprotein (non-HDL) cholesterol measure is aPalabras claves:atherosclerosis, LDL, Non-HDL cholesterolAutores:Castro J., Contreras F., Dowling V., González M.C., Guerra-Torres X.E., Lares M., Rojas-Quintero J., Valmore Bermúdez, Velasco M.Fuentes:scopusEffects of metoclopramide and metoclopramide/dopamine on blood pressure and insulin release in normotensive, hypertensive, and type 2 diabetic subjects
ArticleAbstract: The objective is to determine cardiovascular and insulin release effects under metoclopramide (MTC)Palabras claves:dopamine, Dopamine receptors, Hypertension, Insulin release, Metoclopramide, Type 2 DiabetesAutores:Bolívar H., Cano R.A., Contreras F., Fouillioux C., González M.C., Hernández-Hernandez R., Lares M., Valmore Bermúdez, Velasco M.Fuentes:scopusHaemodynamical variables versus endothelial hormones in hypertensive and type 2 diabetic patients with endothelial dysfunction
ArticleAbstract: Leptin is a 167 aminoacid peptidic hormone secreted by adipose tissue. It works mainly in the hypothPalabras claves:C reactive protein, Hypertension, leptin, Nitric oxide, Type 2 Diabetes mellitusAutores:Cano R.A., Contreras F., Fouillioux C., González M.C., Gotera D., Lares M., Magaldi L., Mayda C.L., Pacheco B., Rojas-Quintero J., Valmore Bermúdez, Velasco M.Fuentes:scopusExploring phytotherapeutic alternatives for obesity, insulin resistance and diabetes mellitus
ReviewAbstract: At present, the pathologic spectrum of obesity-insulin resistance (IR)-diabetes mellitus (DM) repre-Palabras claves:Cardiovascular disease, diabetes mellitus, Insulin Resistance, Medicinal herbs, obesity, PhytotherapyAutores:Cano-Ponce C., Chávez-Castillo M., Durán P., González M.C., Marquina M., Nuñez V., Ortega A., Pírela D., Rojas M., Rojas-Quintero J., Valmore Bermúdez, Velasco M.Fuentes:scopusEpidemiological behavior of high -sensitivity C-Reactive Protein (hs-CRP) in adult individuals in the Maracaibo city, Venezuela
ArticleAbstract: Objectives: High-sensitivity C-Reactive Protein (hs-CRP) is one of the most applied inflammation marPalabras claves:C-Reactive protein, Cardiovascular disease, Low-grade inflammation, Metabolic syndrome, RISK FACTORSAutores:Aguirre M.A., Añez-Ramos R., Apruzzese V., Bello L.M., Cabrera M., Chávez-Castillo M., Fuenmayor D., González M.C., Marcano R.P., Martínez M.S., Mendoza L., Montiel M., Nava A., Pachano F., Rincón T., Rojas-Quintero J., Salazar-Vílchez J., Toledo A.C., Torres Y., Valmore Bermúdez, Velasco M., Villalobos M.Fuentes:scopus